| Gene symbol | CD80 | Synonyms | B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q13.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD80 molecule | ||||
| GTO ID | GTC1193 |
| Trial ID | NCT00031564 |
| Disease | Kidney Cancer |
| Altered gene | B7-1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | gene-modified cell therapy |
| Co-treatment | IL-2 |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 for Patients With Stage IV Renal Cell Carcinoma |
| Year | 2003 |
| Country | United States |
| Company sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Other ID(s) | MCC-12207|NCI-5090|NCI-G00-1872|0001386 |
| Cohort 1 | |||||||||
|
|||||||||